tiprankstipranks
Sumitomo Dainippon Pharma Co Ltd (DNPUF)
OTHER OTC:DNPUF
US Market

Sumitomo Dainippon Pharma Co (DNPUF) Income Statement

Compare
7 Followers

Sumitomo Dainippon Pharma Co Income Statement

Last quarter (Q2 2024), Sumitomo Dainippon Pharma Co's total revenue was ¥90.07B, an increase of 17.05% from the same quarter last year. In Q2, Sumitomo Dainippon Pharma Co's net income was ¥-48.17B. See Sumitomo Dainippon Pharma Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
¥ 314.56B¥ 555.54B¥ 560.03B¥ 515.95B¥ 482.73B
Gross Profit
¥ 187.98B¥ 376.63B¥ 402.91B¥ 378.18B¥ 353.06B
Operating Expenses
¥ 542.17B¥ 453.60B¥ 342.67B¥ 306.95B¥ 269.82B
Depreciation and Amortization
¥ 37.77B¥ 41.26B¥ 38.35B¥ 22.67B¥ 17.36B
EBITDA
¥ -281.07B¥ -3.50B¥ 124.36B¥ 103.11B¥ 100.29B
Operating Income
¥ -354.19B¥ -76.98B¥ 60.23B¥ 71.22B¥ 83.24B
Other Income/Expenses
¥ 31.08B¥ 29.06B¥ 22.73B¥ 6.63B¥ 708.00M
Pretax Income
¥ -323.11B¥ -47.92B¥ 82.96B¥ 77.85B¥ 83.95B
Net Income
¥ -314.97B¥ -74.51B¥ 56.41B¥ 56.22B¥ 40.75B
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ -792.79¥ -187.55¥ 141.99¥ 141.50¥ 102.58
Diluted EPS
¥ -792.79¥ -187.55¥ 141.99¥ 141.50¥ 102.58
Weighted Average Shares Outstanding
397.29M 397.29M 397.29M 397.29M 397.30M
Weighted Average Shares Outstanding (Diluted)
397.29M 397.29M 397.29M 397.29M 397.30M
Currency in JPY

Sumitomo Dainippon Pharma Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis